Regencell Bioscience Holdings Limited Ordinary Shares (RGC)
Regencell Bioscience Holdings Limited Ordinary Shares (RGC) is listed on Nasdaq, where it has traded since July 16, 2021.
- Listed On
- Nasdaq
- Listed Since
- July 16, 2021
- Employees
- 10
- Market Cap
- $3.1B
About Regencell Bioscience Holdings Limited Ordinary Shares
Regencell Bioscience Holdings Ltd is a bioscience company focusing on the research, development, and commercialization of TCM for the treatment of neurocognitive disorders and degenerations, specifically ADHD and ASD, and infectious diseases affecting people's immune systems.
Institutional ownership
In 13F filings for the quarter ended June 30, 2026, 34 institutions reported holding RGC, with 1.4 million shares worth $8.3 million in aggregate. The largest reported holder was Geode Capital Management, with 422,011 shares worth $2.6 million. Of the 5 largest holders listed below, 3 opened new positions in RGC and 2 added shares during the quarter.
| Institution | Shares | Value | Quarter change |
|---|---|---|---|
| Geode Capital Management | 422,011 | $3M | Added 1.55% |
| Alyeska Investment Group, | 416,261 | $3M | New position |
| Legal & General Group | 128,000 | $779K | Added 1192.54% |
| Jane Street Group | 98,348 | $599K | New position |
| Xtx Topco | 60,061 | $366K | New position |
Form 13F is a quarterly report that institutional investment managers with at least $100 million in qualifying securities file with the SEC. It lists long positions as of the last day of the quarter and is due within 45 days of quarter end, so these holdings describe that date rather than today.
Frequently asked questions
What is RGC?
Regencell Bioscience Holdings Limited Ordinary Shares (RGC) is listed on Nasdaq, where it has traded since July 16, 2021.
Who are the largest institutional holders of RGC?
In 13F filings for the quarter ended June 30, 2026, the largest reported holders of RGC were Geode Capital Management, Alyeska Investment Group, and Legal & General Group.
How many institutions own RGC?
34 institutions reported a position in RGC for the quarter ended June 30, 2026, worth $8.3 million in total.
Did institutions buy or sell RGC last quarter?
Of the 5 largest reported holders, 3 opened new positions in RGC and 2 added shares during the quarter. Every reported holder and its change is on the SentiSense ownership page for RGC.
Every reported institutional holder, plus insider and congressional trades in RGC, on SentiSense.